Marché mondial de la culture cellulaire 3D – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse et taille du marché de la culture cellulaire 3D

Le marché de la culture cellulaire 3D connaît une croissance significative, propulsée par la demande croissante et l'intégration de la technologie microfluidique. Ce passage des méthodes de culture cellulaire traditionnelles aux techniques 3D devrait remodeler le paysage industriel. En outre, l'augmentation du financement des projets de recherche doctorale utilisant cette technologie devrait stimuler davantage la demande de systèmes de culture tridimensionnels, favorisant ainsi l'expansion du marché.

Le lancement de l'hydrogel JellaGel par Jellagen Limited en 2021 s'inscrit dans la dynamique du marché de la culture cellulaire 3D, offrant aux chercheurs une nouvelle solution d'hydrogel non mammalien dérivée du collagène de méduse. Cette innovation répond à la demande de l'industrie pour des processus expérimentaux simplifiés et cohérents, reflétant l'évolution continue vers des techniques 3D avancées et favorisant une croissance supplémentaire du marché grâce à des résultats de recherche améliorés.

Français La taille du marché mondial de la culture cellulaire 3D était évaluée à 2,36 milliards USD en 2023 et devrait atteindre 5,52 milliards USD d'ici 2031, avec un TCAC de 11,20 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché       

Market Definition

3D cell culture, also known as 3D cellular models, is an advanced method where cells are grown in an artificial environment that mimics their natural surroundings, enabling them to grow and interact in three dimensions. This technique enhances cell differentiation and migration compared to traditional 2D cultures, leading to improved tissue maturation and organization. It finds extensive applications in pharmaceutical, biotechnology, and academic research settings for studying complex cellular behaviors and responses.

3D Cell Culture Market Dynamics

Drivers

• Expanding Use of 3D Cell Culture in Regenerative Medicine

This innovative technique allows for the creation of complex tissue models that closely mimic native tissue environments, making it invaluable for studying tissue regeneration and engineering. As regenerative medicine continues to gain traction as a promising approach for treating various diseases and injuries, the demand for advanced cell culture technologies such as 3D models is escalating. Consequently, this growing application area is fueling the expansion of the 3D cell culture market, as researchers and clinicians seek more accurate and reliable methods for studying and implementing regenerative therapies.

• Growing Investment in Healthcare Facilities Emphasis on Precise Medicine

As healthcare institutions expand and modernize their infrastructure, there is a heightened focus on adopting advanced technologies to improve research and treatment outcomes. This investment creates a conducive environment for the adoption of 3D cell culture techniques, as they offer more physiologically relevant models for drug discovery, disease modeling, and personalized medicine. Moreover, the emphasis on precision medicine and the need for more accurate preclinical models further incentivize healthcare facilities to invest in 3D cell culture technology, thereby driving market growth.

Opportunities

• Growing Strategic Initiatives by Market Players Enhances Product Offerings

With 3D cell culture techniques, researchers can better mimic the complex cellular environments necessary for organ growth and regeneration. This technology enables the development of more accurate and reliable models for studying tissue engineering, organogenesis, and drug discovery. As the demand for effective treatments and therapies in organ transplantation and regenerative medicine grows, the adoption of 3D cell culture methods is poised to play a pivotal role in advancing research and clinical applications in these fields.

• Growing Technological Advancements Increases the Adoption of 3D Cell Culture

Innovations such as microfluidics integration, advanced biomaterials, and high-throughput screening techniques are enhancing the efficacy and scalability of 3D cell culture systems. These advancements enable more accurate modeling of complex biological processes and disease states, thereby increasing the relevance of in vitro studies for drug discovery and development. Moreover, the integration of automation and artificial intelligence in 3D cell culture workflows streamlines experimentation, reduces costs, and accelerates research timelines, driving adoption across pharmaceutical, biotechnology, and academic sectors. As these technologies continue to evolve, they promise to unlock new avenues for precision medicine and personalized therapeutics, further fueling the growth of the 3D cell culture market.

Amerigo Scientific's expansion of its cell culture portfolio in August 2021 highlights the growing market opportunity in 3D cell culture. It introduces a new 3D cell culture system tailored for scientific applications such as drug discovery, medicine, nanomaterial evaluation, and basic life science research, Amerigo Scientific is capitalizing on the increasing demand for advanced cell culture technologies. This move underscores the industry's momentum towards leveraging innovative solutions to enhance research efficacy and address complex biological challenges.

Restraints/Challenges

• High Cost of Implementation Limits the Adoption of 3D Cell Culture Techniques

Setting up and maintaining 3D cell culture systems requires significant investment in specialized equipment, consumables, and expertise. This cost burden can deter smaller research laboratories and academic institutions with limited budgets from adopting 3D cell culture techniques. Additionally, ongoing expenses associated with purchasing culture media, growth factors, and other reagents contribute to the overall financial strain. Consequently, while the technology holds promise for advancing research and development efforts, its accessibility remains limited due to the financial barriers posed by its high implementation costs.

• Increased Complexity in Standardization Hampers Reliability of Data

The poses a significant restraint to the growth of the 3D cell culture market. With the diverse range of techniques and materials used in 3D cell culture, achieving consistent and reproducible results across different laboratories and research settings becomes challenging. Lack of standardized protocols and methods hampers comparability and reliability of data, hindering widespread adoption of 3D cell culture technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2023, Curi bio introduced Nautilus and Stringray platforms, aimed at aiding researchers in conducting electrophysiological interrogation in both 2D and 3D cell culture settings, enhancing their capabilities in cellular analysis
• In 2023, REPROCELL Inc. collaborated with Vernal Biosciences to offer scalable mRNA services in Japan, indicating a strategic move to cater to the evolving needs of the 3D cell culture market. This partnership reflects a trend towards integrating advanced technologies such as mRNA into 3D cell culture systems, facilitating more precise and efficient research and clinical applications
• In 2023, 3D BioFibR secured a substantial investment of nearly USD 3.52 million to expand its facility and introduce collagen fiber products for 3D bioprinting applications, reflecting growing interest and investment in advanced biofabrication technologies
• In 2022, Avantor collaborated with GeminiBio to enhance bioproduction workflow solutions, aligning with the demands of the expanding 3D cell culture market. This collaboration underscores the importance of streamlining supply chains and offering comprehensive solutions for researchers adopting 3D cell culture techniques, ensuring access to high-quality biological products and reagents
• In 2022, Lonza collaborated with Israel Biotech Fund (IBF) to accelerate the production and development of small molecules and biologics, echoing the market's growing emphasis on innovation and collaboration. This partnership signifies the significance of accessing diverse pools of expertise and resources, which can lead to breakthroughs in 3D cell culture methodologies and applications, ultimately driving market advancement

3D Cell Culture Market Scope

The market is segmented on the basis of product, type, application, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Scaffold-Based
  • Hydrogels/ECM Analogs
  • Solid Scaffolds
  • Micropatterned Surfaces
• Scaffold-Free
  • Hanging Drop Microplates
  • Spheroid Microplates with ULA Coating
  • Magnetic Levitation
• 3D Bioreactors
• 3D Petri Dishes
• Microfluidics-Based
• Magnetic Levitation and 3d Bio-Printing

 Type

• Hydrogel
• Hanging Drop
• Bioreactor
• Microfluidics
• Magnetic Levitation

Application

• Cancer and Stem Cell Research
• Drug Discovery and Toxicology Testing
• Tissue Engineering and Regenerative Medicine

 End User

• Pharmaceutical and Biotechnology Companies
• Academic
• Institutes
• Research Laboratories

 3D Cell Culture Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, product, type, application and end use as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.

North America is expected to dominate the market primarily due to its access to advanced technologies for cancer treatment and the robust presence of pharmaceutical and biotechnology industries. The region benefits from significant investments in research and development, fostering innovation in therapeutic approaches. Additionally, the presence of leading academic institutions and research centers contributes to a conducive environment for the development and commercialization of novel cancer treatments. These factors collectively position North America as a key driver in advancing the field of oncology and dominating the global market for cancer therapeutics.

L'Asie-Pacifique devrait connaître une croissance rapide au cours de la période de prévision, alimentée par l'importance croissante accordée aux progrès en matière d'administration de médicaments et par l'empreinte croissante des secteurs pharmaceutique et biotechnologique. Le paysage dynamique des soins de santé de la région, associé à des investissements croissants dans la recherche et le développement, favorise l'innovation dans les technologies d'administration de médicaments. En outre, les initiatives gouvernementales favorables et les collaborations avec les institutions universitaires propulsent la croissance des industries pharmaceutiques et biotechnologiques en Asie-Pacifique. Ces facteurs positionnent collectivement la région comme un pôle d'innovation et d'expansion du marché dans le secteur de l'administration de médicaments.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

Le marché vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les biens d'équipement, la base installée de différents types de produits pour le marché, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché. Les données sont disponibles pour la période historique 2016-2021.

Analyse du paysage concurrentiel et du marché de la culture cellulaire 3D

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché de la culture cellulaire 3D.

Certains des principaux acteurs opérant sur le marché sont :

• REPROCELL Inc. (Japon)
• SYNTHECON, INCORPORATED (ÉTATS-UNIS)
• InSphero (Suisse)
• Merck KGaA (Allemagne)
• VWR International, LLC. (États-Unis)
• Lonza (Suisse)
• Agilent Technologies (États-Unis)
• Corning Incorporated (États-Unis)
• Cell Culture Company, LLC (États-Unis)
• Instruments avancés (États-Unis)
• SHIBUYA CORPORATION (Japon)
• NanoEntek (États-Unis)
• FUJIFILM Holdings America Corporation (États-Unis)
• Hitachi, Ltd. (Japon)
• Thermo Fisher Scientific Holdings, Inc. (États-Unis)
• BD (États-Unis)

SKU-14395